17-8015920-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BA1BP4

This summary comes from the ClinGen Evidence Repository: The variant NM_000180.4(GUCY2D):c.3044-7G>T is located in intron 16. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.04452, with 52,788 alleles / 1,177,142 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in >6 adult individuals in gnomAD (1363 individuals, gnomAD version 4.1.0; BS2). In addition, the splicing impact predictor SpliceAI gives a delta score of 0.04, which is below the ClinGen LCA / eoRD VCEP recommended threshold of ≥0.2 and does not strongly predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA8366302/MONDO:0100453/167

Frequency

Genomes: 𝑓 0.028 ( 97 hom., cov: 33)
Exomes 𝑓: 0.038 ( 1266 hom. )

Consequence

GUCY2D
NM_000180.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00003016
2

Clinical Significance

Benign reviewed by expert panel B:5

Conservation

PhyloP100: -1.39
Variant links:
Genes affected
GUCY2D (HGNC:4689): (guanylate cyclase 2D, retinal) This gene encodes a retina-specific guanylate cyclase, which is a member of the membrane guanylyl cyclase family. Like other membrane guanylyl cyclases, this enzyme has a hydrophobic amino-terminal signal sequence followed by a large extracellular domain, a single membrane spanning domain, a kinase homology domain, and a guanylyl cyclase catalytic domain. In contrast to other membrane guanylyl cyclases, this enzyme is not activated by natriuretic peptides. Mutations in this gene result in Leber congenital amaurosis and cone-rod dystrophy-6 diseases. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GUCY2DNM_000180.4 linkc.3044-7G>T splice_region_variant, intron_variant Intron 16 of 19 ENST00000254854.5 NP_000171.1 Q02846
GUCY2DXM_011523816.2 linkc.3044-7G>T splice_region_variant, intron_variant Intron 15 of 18 XP_011522118.1 Q02846

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GUCY2DENST00000254854.5 linkc.3044-7G>T splice_region_variant, intron_variant Intron 16 of 19 1 NM_000180.4 ENSP00000254854.4 Q02846
ENSG00000279174ENST00000623126.1 linkn.459C>A non_coding_transcript_exon_variant Exon 1 of 1 6
GUCY2DENST00000574510.1 linkn.-209G>T upstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0281
AC:
4269
AN:
152176
Hom.:
97
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00799
Gnomad AMI
AF:
0.119
Gnomad AMR
AF:
0.0226
Gnomad ASJ
AF:
0.0487
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0444
Gnomad OTH
AF:
0.0330
GnomAD3 exomes
AF:
0.0279
AC:
6685
AN:
239362
Hom.:
144
AF XY:
0.0286
AC XY:
3708
AN XY:
129876
show subpopulations
Gnomad AFR exome
AF:
0.00727
Gnomad AMR exome
AF:
0.0157
Gnomad ASJ exome
AF:
0.0496
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00588
Gnomad FIN exome
AF:
0.0188
Gnomad NFE exome
AF:
0.0449
Gnomad OTH exome
AF:
0.0305
GnomAD4 exome
AF:
0.0383
AC:
55744
AN:
1455586
Hom.:
1266
Cov.:
32
AF XY:
0.0378
AC XY:
27327
AN XY:
723614
show subpopulations
Gnomad4 AFR exome
AF:
0.00620
Gnomad4 AMR exome
AF:
0.0173
Gnomad4 ASJ exome
AF:
0.0487
Gnomad4 EAS exome
AF:
0.0000760
Gnomad4 SAS exome
AF:
0.00634
Gnomad4 FIN exome
AF:
0.0201
Gnomad4 NFE exome
AF:
0.0449
Gnomad4 OTH exome
AF:
0.0327
GnomAD4 genome
AF:
0.0280
AC:
4265
AN:
152294
Hom.:
97
Cov.:
33
AF XY:
0.0269
AC XY:
2004
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.00794
Gnomad4 AMR
AF:
0.0226
Gnomad4 ASJ
AF:
0.0487
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00538
Gnomad4 FIN
AF:
0.0170
Gnomad4 NFE
AF:
0.0444
Gnomad4 OTH
AF:
0.0326
Alfa
AF:
0.0312
Hom.:
37
Bravo
AF:
0.0276
Asia WGS
AF:
0.00491
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 19, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

GUCY2D-related recessive retinopathy Benign:1
Jan 30, 2025
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The variant NM_000180.4(GUCY2D):c.3044-7G>T is located in intron 16. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.04452, with 52,788 alleles / 1,177,142 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in >6 adult individuals in gnomAD (1363 individuals, gnomAD version 4.1.0; BS2). In addition, the splicing impact predictor SpliceAI gives a delta score of 0.04, which is below the ClinGen LCA / eoRD VCEP recommended threshold of ≥0.2 and does not strongly predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.7
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000030
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56348143; hg19: chr17-7919238; API